JRSIS Health Care Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.13246 million compared to net income of USD 0.541495 million a year ago. Basic loss per share from continuing operations was USD 0.023 compared to USD 0.004 a year ago. Diluted loss per share from continuing operations was USD 0.023 compared to USD 0.004 a year ago. Basic loss per share was USD 0.023 compared to basic earnings per share of USD 0.291 a year ago. Diluted loss per share was USD 0.023 compared to diluted earnings per share of USD 0.287 a year ago.
For the nine months, net loss was USD 33.68 million compared to net income of USD 2.06 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.021 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.021 a year ago. Basic loss per share was USD 8.298 compared to basic earnings per share of USD 1.12 a year ago. Diluted loss per share was USD 8.298 compared to diluted earnings per share of USD 1.108 a year ago.